Skip to content

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System

A Multicentre Observational Study to Evaluate Clinical Outcomes of the G7 Acetabular System

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02036931
Enrollment
162
Registered
2014-01-15
Start date
2013-03-31
Completion date
2025-05-31
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Noninflammatory Degenerative Joint Disease, Rheumatoid Arthritis

Keywords

Joint, Osteoarthritis, Avascular Necrosis

Brief summary

This is a prospective observational multi-center non-controlled study. The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System.

Detailed description

This is a prospective observational multi-center non-controlled study. The primary purpose of this study is to evaluate the clinical and radiographic performance of the G7 Acetabular Cup System in both primary and revision procedures, report safety and survivorship, and document instrument ease of use. Preoperative and intraoperative data have been collected retrospectively and follow ups have been collected prospectively. Clinical outcomes included the Harris Hip Score, Oxford Hip Score, and Radiographic Evaluations collected at 3 month, 1, 2 and 5 year follow-up time points. For the 7 and 10 year follow-up intervals, survivorship and adverse events have been collected.

Interventions

DEVICEMetal on Polyethylene articulation

G7 Acetabular Cup System with Metal head on Polyethylene liner articulation (MOP)

DEVICECeramic on Polyethylene articulation

G7 Acetabular Cup System with Ceramic head on Polyethylene liner articulation (COP)

DEVICECeramic on Ceramic articulation

G7 Acetabular Cup System with Ceramic head on Ceramic linear articulation (COC) - Outside the United States ONLY

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Noninflammatory degenerative joint disease including osteoarthritis and avascular necrosis * Rheumatoid arthritis * Correction of functional deformity * Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques * Revision procedures where other treatment or devices have failed * 18 years of age or older * Subjects willing to return for follow-up evaluations

Exclusion criteria

* Infection, sepsis and osteomyelitis * Subjects unable to cooperate with and complete the study * Neurological conditions affecting movement * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Harris Hip ScorePre-operative,1, 2, and 5 years postoperativelyThe Harris Hip Scale (HHS) is an outcome measure that includes a series of questions answered by the patient and physical examinations recorded by a qualified health care professional. The HHS covers four domains: pain (one item, 0-44 points), function and functional activities (seven items, 0-47 points), absence of deformity (one item, 0-4 points) and range of motion (one item, o-5 points). To obtain a final score, the points are summed. The outcome score can be categorized as Excellent:90 - 100; Good: 80 - 90; Fair: 70 - 80; Poor: \< 70.

Secondary

MeasureTime frameDescription
Oxford Hip ScorePre-op, 1, 2, and 5 years postoperativelyThe Oxford Hip Score (OHS) is a patient-reported outcome measure that was developed to specifically assess the patient's perspective of outcome following THA. The OHS consists of twelve questions covering function and pain associated with the hip. To calculate the total score, each response is scored from 0 (worst outcome) to 4 (best outcome) and the sum of all 12 items is reported with a maximum of 48, representing the best score possible. The outcome score can be categorized as Excellent: \> 41; Good: 34 - 41; Fair: 27 - 33; Poor: \< 27.
Survivorship7 and 10 Year post-operativeFraction of patients without a revision of any of the hip implant component, calculated with the Kaplan Meier (K-M) estimate.
Radiographic EvaluationImmediate post-op, 3 months, 1, 2, and 5 yearsAll radiographs have been reviewed by the investigators at each site in order to detect and report any abnormal and significant findings (including adverse events). The change from the angle of inclination between the different follow-ups is shown in the table.

Countries

France, Germany, Ireland, Netherlands, Spain, United States

Participant flow

Participants by arm

ArmCount
Metal on Polyethylene Articulation
G7 cup with Metal on Polyethylene articulation (MOP)
96
Ceramic on Polyethylene Articulation
G7 cup with Ceramic on Polyethylene articulation (COP)
37
Ceramic on Ceramic Articulation
G7 cup with Ceramic on Ceramic articulation (COC)
29
Total162

Baseline characteristics

CharacteristicTotalMetal on Polyethylene ArticulationCeramic on Polyethylene ArticulationCeramic on Ceramic Articulation
Age, Continuous66 Years68.8 Years61 Years61 Years
Harris Hip Score46.1 Scores
STANDARD_DEVIATION 15.7
45.8 Scores
STANDARD_DEVIATION 16.7
43.1 Scores
STANDARD_DEVIATION 12.6
50.7 Scores
STANDARD_DEVIATION 15.4
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
79 Participants46 Participants26 Participants7 Participants
Sex: Female, Male
Male
83 Participants50 Participants11 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
5 / 961 / 373 / 29
other
Total, other adverse events
4 / 960 / 370 / 29
serious
Total, serious adverse events
19 / 969 / 3713 / 29

Outcome results

Primary

Harris Hip Score

The Harris Hip Scale (HHS) is an outcome measure that includes a series of questions answered by the patient and physical examinations recorded by a qualified health care professional. The HHS covers four domains: pain (one item, 0-44 points), function and functional activities (seven items, 0-47 points), absence of deformity (one item, 0-4 points) and range of motion (one item, o-5 points). To obtain a final score, the points are summed. The outcome score can be categorized as Excellent:90 - 100; Good: 80 - 90; Fair: 70 - 80; Poor: \< 70.

Time frame: Pre-operative,1, 2, and 5 years postoperatively

Population: The number of participants decreased around the 5-year visit due to substantial patient loss at certain sites.

ArmMeasureGroupValue (MEAN)Dispersion
Metal on Polyethylene articulationHarris Hip ScorePre-op45.8 ScoreStandard Deviation 16.7
Metal on Polyethylene articulationHarris Hip Score1 Year95.4 ScoreStandard Deviation 7.4
Metal on Polyethylene articulationHarris Hip Score2 Year96.1 ScoreStandard Deviation 6.4
Metal on Polyethylene articulationHarris Hip Score5 Year94.8 ScoreStandard Deviation 7.1
Ceramic on Polyethylene articulationHarris Hip Score5 Year91.7 ScoreStandard Deviation 6.8
Ceramic on Polyethylene articulationHarris Hip ScorePre-op43.1 ScoreStandard Deviation 12.6
Ceramic on Polyethylene articulationHarris Hip Score2 Year93.4 ScoreStandard Deviation 9.5
Ceramic on Polyethylene articulationHarris Hip Score1 Year94.2 ScoreStandard Deviation 7.3
Ceramic on Ceramic articulationHarris Hip Score5 Year94.1 ScoreStandard Deviation 7.8
Ceramic on Ceramic articulationHarris Hip Score1 Year92.8 ScoreStandard Deviation 10
Ceramic on Ceramic articulationHarris Hip Score2 Year94.3 ScoreStandard Deviation 8.7
Ceramic on Ceramic articulationHarris Hip ScorePre-op50.7 ScoreStandard Deviation 15.4
Secondary

Oxford Hip Score

The Oxford Hip Score (OHS) is a patient-reported outcome measure that was developed to specifically assess the patient's perspective of outcome following THA. The OHS consists of twelve questions covering function and pain associated with the hip. To calculate the total score, each response is scored from 0 (worst outcome) to 4 (best outcome) and the sum of all 12 items is reported with a maximum of 48, representing the best score possible. The outcome score can be categorized as Excellent: \> 41; Good: 34 - 41; Fair: 27 - 33; Poor: \< 27.

Time frame: Pre-op, 1, 2, and 5 years postoperatively

Population: The number of participants decreased around the 5-year visit due to substantial patient loss at certain sites.

ArmMeasureGroupValue (MEAN)Dispersion
Metal on Polyethylene articulationOxford Hip ScorePre-op19.6 ScoreStandard Deviation 9.1
Metal on Polyethylene articulationOxford Hip Score5 Year46.5 ScoreStandard Deviation 2.4
Metal on Polyethylene articulationOxford Hip Score1 Year46.1 ScoreStandard Deviation 3.3
Metal on Polyethylene articulationOxford Hip Score2 Year46.7 ScoreStandard Deviation 2.4
Ceramic on Polyethylene articulationOxford Hip ScorePre-op16.2 ScoreStandard Deviation 6.3
Ceramic on Polyethylene articulationOxford Hip Score5 Year45.8 ScoreStandard Deviation 2.4
Ceramic on Polyethylene articulationOxford Hip Score1 Year45.4 ScoreStandard Deviation 3.3
Ceramic on Polyethylene articulationOxford Hip Score2 Year45.2 ScoreStandard Deviation 5.1
Ceramic on Ceramic articulationOxford Hip Score5 Year43.4 ScoreStandard Deviation 7.9
Ceramic on Ceramic articulationOxford Hip ScorePre-op22.7 ScoreStandard Deviation 9
Ceramic on Ceramic articulationOxford Hip Score2 Year44.4 ScoreStandard Deviation 6.1
Ceramic on Ceramic articulationOxford Hip Score1 Year45.4 ScoreStandard Deviation 2.9
Secondary

Radiographic Evaluation

All radiographs have been reviewed by the investigators at each site in order to detect and report any abnormal and significant findings (including adverse events). The change from the angle of inclination between the different follow-ups is shown in the table.

Time frame: Immediate post-op, 3 months, 1, 2, and 5 years

Population: The number of cases decreased around 5 years because two sites discontinued the study.

ArmMeasureGroupValue (MEAN)Dispersion
Metal on Polyethylene articulationRadiographic Evaluation5 Years39.6 DegreeStandard Deviation 4.3
Metal on Polyethylene articulationRadiographic EvaluationImmediate Post-Op43.2 DegreeStandard Deviation 5.8
Metal on Polyethylene articulationRadiographic Evaluation1 Year42.3 DegreeStandard Deviation 5.7
Metal on Polyethylene articulationRadiographic Evaluation3 Months42.8 DegreeStandard Deviation 5.4
Metal on Polyethylene articulationRadiographic Evaluation2 Years42.7 DegreeStandard Deviation 5.9
Ceramic on Polyethylene articulationRadiographic Evaluation3 Months41.8 DegreeStandard Deviation 5.5
Ceramic on Polyethylene articulationRadiographic Evaluation5 Years41.8 DegreeStandard Deviation 4
Ceramic on Polyethylene articulationRadiographic Evaluation2 Years42.0 DegreeStandard Deviation 5.4
Ceramic on Polyethylene articulationRadiographic EvaluationImmediate Post-Op41.9 DegreeStandard Deviation 5.7
Ceramic on Polyethylene articulationRadiographic Evaluation1 Year42.4 DegreeStandard Deviation 5.1
Ceramic on Ceramic articulationRadiographic Evaluation5 Years38.0 DegreeStandard Deviation 6.9
Ceramic on Ceramic articulationRadiographic EvaluationImmediate Post-Op37.2 DegreeStandard Deviation 6.1
Ceramic on Ceramic articulationRadiographic Evaluation3 Months37.2 DegreeStandard Deviation 6.1
Ceramic on Ceramic articulationRadiographic Evaluation2 Years37.6 DegreeStandard Deviation 6.1
Ceramic on Ceramic articulationRadiographic Evaluation1 Year37.3 DegreeStandard Deviation 6.3
Secondary

Survivorship

Fraction of patients without a revision of any of the hip implant component, calculated with the Kaplan Meier (K-M) estimate.

Time frame: 7 and 10 Year post-operative

Population: The K-M survival for CoP and CoC groups were only calculated up to 7 years because less than 20 cases remained at risk after that timepoint, which was below the level of detection to calculate a reliable Kaplan Meier estimate.

ArmMeasureGroupValue (NUMBER)
Metal on Polyethylene articulationSurvivorship10 Year0.9762 proportion of participants
Metal on Polyethylene articulationSurvivorship7 Year0.9762 proportion of participants
Ceramic on Polyethylene articulationSurvivorship10 YearNA proportion of participants
Ceramic on Polyethylene articulationSurvivorship7 Year0.9697 proportion of participants
Ceramic on Ceramic articulationSurvivorship7 Year1.0000 proportion of participants
Ceramic on Ceramic articulationSurvivorship10 YearNA proportion of participants
Secondary

Survivorship

Fraction of patients without a revision of any of the hip implant component, calculated with the Kaplan Meier (K-M) estimate.

Time frame: 10 Year post-operative

Population: A Kaplan-Meier survival analysis was performed for all cases including 39 from MoP arm, 16 from CoP arm, 13 from CoC arm.

ArmMeasureValue (NUMBER)
Metal on Polyethylene articulationSurvivorship0.9818 proportion of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026